40.34USD+35.60%Mkt Cap: 2.08B $P/E: —1d ago
CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-…
Industry Peers
Diagnostics & Research$201.86BUSDP/E 29.8
$145.10BUSDP/E 39.7
$45.85BUSDP/E 44.2
$45.44BUSDP/E 42.4
$38.64BUSD
$38.44BUSDP/E 27.3
$37.13BUSDP/E 48.1
$35.13BUSDP/E 26.2
$28.78BUSDP/E 34.6
$26.98BUSDP/E 31.4
$23.18BUSDP/E 23.1
$23.12BUSDP/E 25.0
$20.55BUSD
$15.36BUSDP/E 33.9
$13.06BUSDP/E 27.3
$12.46BUSDP/E 53.7
$11.04BUSD
$9.26BUSDP/E 21.6
$5.90BUSDP/E 237.4
$5.68BUSD
$5.21BUSDP/E 44.6
$4.95BUSD
$4.73BUSDP/E 54.8
$3.75BUSDP/E 26.5
$3.54BUSD
$3.09BUSD
$1.93BUSD
$1.83BUSD
$1.64BUSDP/E 41.7
$1.63BUSD
$1.48BUSDP/E 22.4
$1.02BUSDP/E 21.4
$898.56MUSD
$734.89MUSD
$616.40MUSDP/E 40.2
$584.63MUSD
$583.63MUSD
$293.12MUSDP/E 2.9
$292.75MUSD
$206.70MUSD
$152.09MUSD
$139.43MUSD
$97.25MUSD
$102.68MUSD
$89.37MUSDP/E 17.2
$73.19MUSD
$58.55MUSD
$42.32MUSD
$30.71MUSD
$26.61MUSD
$20.94MUSD
$16.60MUSD
$12.04MUSD
$9.95MUSD
$8.70MUSD
$8.87MUSD
$7.73MUSD
$7.43MUSD
$6.69MUSD
$6.06MUSD
$5.06MUSD
$4.47MUSD
$4.44MUSD
$2.95MUSD
$3.29MUSD
$3.18MUSD
$869.0KUSD
$314.2KUSDP/E Infinity
$19.6KUSD
Indicators:|
| Headline | Source | Time |
|---|---|---|
Yesterday | ||
 CareDx shares jump as Medicare finalizes transplant testing coverage policy (CDNA) Final Medicare policy supports transplant surveillance portfolioCareDx Inc. (NASDAQ:CDNA) shares climbed 20% on Thursday after the company announced that Medicare had finalized its Local Coverage Determination (LCD) covering molecular testing for solid organ transplant rejection. | ||
Older | ||